Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.
Press releases published on April 4, 2025
Arqit Quantum Inc. Announces Select Preliminary Financial Results for First Half of Fiscal Year 2025
GlobeNewswire
·
April 4, 2025
LONDON, April 04, 2025 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (“Arqit”), a global leader in quantum-safe encryption, announces select preliminary financial results for the first half of fiscal year 2025. Based on preliminary unaudited results, management …
SIMPPLE Ltd. Wins Second Contract, Worth $524,000, to Supply Autonomous Cleaning Robots at Singapore Airport Terminal
GlobeNewswire
·
April 4, 2025
Singapore, April 04, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management (FM) sector, today announced the Company has been awarded a follow-up contract, …
Vimeo Announces ‘Vimeo Streaming’: a New Era of Video Monetization, Control, and Discovery on Every Screen
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: VMEO) - Vimeo, the world’s most innovative video platform for creators and businesses, introduced the next era of content delivery and monetization with the launch of Vimeo Streaming. Any creator, big …
Regency Centers Invites You to Join Its First Quarter 2025 Earnings Conference Call
GlobeNewswire
·
April 4, 2025
JACKSONVILLE, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its first quarter 2025 earnings results on Tuesday, April 29, 2025, after the market closes. The Company’s …
SEALSQ Unaffected by New Tariffs: Semiconductor Exemption Ensures Continuity, Bolstered by Company’s Innovation, U.S. Development Roadmap, and Post-Quantum Compliance
GlobeNewswire
·
April 4, 2025
Geneva, Switzerland, April 04, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today confirmed …
Tr1X Awarded $8 Million CIRM Grant to Support TRX103 Phase 1/2a Clinical Trial for Graft-Versus-Host Disease
GlobeNewswire
·
April 4, 2025
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell therapies with the potential to cure autoimmune and inflammatory …
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and …
Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee
GlobeNewswire
·
April 4, 2025
PALO ALTO, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today …
FOREWARN to Provide Identity Verification Services to Little Rock REALTORS® Association to Promote Agent Safety
GlobeNewswire
·
April 4, 2025
BOCA RATON, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Little Rock REALTORS® Association (“LRRA”) will …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
DALLAS, April 04, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of …
Carpenter Technology Announces Conference Call and Webcast
GlobeNewswire
·
April 4, 2025
PHILADELPHIA, April 04, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, April 24, 2025 at 10:00 a.m. ET to discuss the results of operations for the third quarter of fiscal year …
Tabhi acquires Mondee out of Chapter 11 Restructuring and Boosts Liquidity and Capital Structure
GlobeNewswire
·
April 4, 2025
AUSTIN, Texas, April 04, 2025 (GLOBE NEWSWIRE) -- Mondee Holdings, Inc. announces its acquisition by Tabhi, and exit from Chapter 11 restructuring. Tabhi acquired substantially all the assets of Mondee Holdings, Inc. and strengthened its balance sheet by …
Genius Group files RICO lawsuit against Michael Moe and Peter Ritz, seeks over $450 million in damages
GlobeNewswire
·
April 4, 2025
SINGAPORE, April 04, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it has filed a lawsuit against Peter Ritz and Michael Moe …
Chart Industries to Announce First Quarter 2025 Results on May 1
GlobeNewswire
·
April 4, 2025
ATLANTA, April 04, 2025 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a global leader in energy and industrial gas solutions, has scheduled a conference call for Thursday, May 1, 2025 at 8:30 a.m. ET to discuss its first quarter 2025 …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …
Arvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation
GlobeNewswire
·
April 4, 2025
– Data demonstrate that ARV-102 was well tolerated, orally bioavailable, and brain-penetrant; ARV-102 achieved central and peripheral LRRK2 reduction indicating substantial LRRK2 protein degradation in healthy volunteers – – Findings support continued …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
RESEARCH TRIANGLE PARK, N.C., April 04, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired employees restricted stock units (RSUs) …
AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States
GlobeNewswire
·
April 4, 2025
LONDON and PHOENIX, April 04, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature …
NextCure to Present at 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 4, 2025
BELTSVILLE, Md., April 04, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it …
ISC Announces Filing of 2025 Management Information Circular
GlobeNewswire
·
April 4, 2025
REGINA, Saskatchewan, April 04, 2025 (GLOBE NEWSWIRE) -- Information Services Corporation (TSX:ISC) (“ISC” or the “Company”) announced today that it has filed its notice of meeting and management information circular for ISC’s May 13, 2025 annual meeting ( …